| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |